Induction chemotherapy with capecitabine and oxaliplatin followed by chemoradiotherapy before total mesorectal excision in patients with locally advanced rectal cancer

Ferlay, 2007, Estimates of the cancer incidence and mortality in Europe in 2006, Ann Oncol, 18, 581, 10.1093/annonc/mdl498 Bray, 2002, Estimates of cancer incidence and mortality in Europe in 1995, Eur J Cancer, 38, 99, 10.1016/S0959-8049(01)00350-1 Heald, 1998, Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997, Arch Surg, 133, 894, 10.1001/archsurg.133.8.894 Havenga, 1999, Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients, Eur J Surg Oncol, 25, 368, 10.1053/ejso.1999.0659 Wibe, 2002, A national strategic change in treatment policy for rectal cancer–implementation of total mesorectal excision as routine treatment in Norway. A national audit, Dis Colon Rectum, 45, 857, 10.1007/s10350-004-6317-7 Glynne-Jones, 2007, The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of rectal cancer, Best Pract Res Clin Gastroenterol, 21, 1049, 10.1016/j.bpg.2007.11.003 Birbeck, 2002, Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery, Ann Surg, 235, 449, 10.1097/00000658-200204000-00001 MERCURY Study Group, 2006, Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study, BMJ, 333, 779, 10.1136/bmj.38937.646400.55 Brown, 2005, Preoperative staging of rectal cancer: the MERCURY research project, Recent Results Cancer Res, 165, 58, 10.1007/3-540-27449-9_8 Hermanek, 1995, Prognostic factors of rectum carcinoma—experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma, Tumori, 81, 60 Nagtegaal, 2005, Low rectal cancer: a call for a change of approach in abdominoperineal resection, J Clin Oncol, 23, 9257, 10.1200/JCO.2005.02.9231 Kapiteijn, 2001, Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer, N Engl J Med, 345, 638, 10.1056/NEJMoa010580 Bosset, 2006, Chemotherapy with preoperative radiotherapy in rectal cancer, N Engl J Med, 355, 1114, 10.1056/NEJMoa060829 Gerard, 2006, Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203, J Clin Oncol, 24, 4620, 10.1200/JCO.2006.06.7629 Bujko, 2004, Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy, Radiother Oncol, 72, 15, 10.1016/j.radonc.2003.12.006 Peeters, 2007, The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma, Ann Surg, 246, 693, 10.1097/01.sla.0000257358.56863.ce Braendengen, 2008, Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer, J Clin Oncol, 26, 3687, 10.1200/JCO.2007.15.3858 Sauer, 2004, Preoperative versus postoperative chemoradiotherapy for rectal cancer, N Engl J Med, 351, 1731, 10.1056/NEJMoa040694 Crane, 2003, The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer, Int J Radiat Oncol Biol Phys, 57, 84, 10.1016/S0360-3016(03)00532-7 Chua, 2010, Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial, Lancet Oncol, 11, 241, 10.1016/S1470-2045(09)70381-X Chau, 2006, Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer, J Clin Oncol, 24, 668, 10.1200/JCO.2005.04.4875 Calvo, 2006, Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation, Ann Oncol, 17, 1103, 10.1093/annonc/mdl085 National Institute of HealthNCI: Common Toxicity CriteriaVersion 2.0 1998http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcv20_4-30-992.pdf Brown, 2005, Thin section MRI in multidisciplinary pre-operative decision making for patients with rectal cancer, Br J Radiol, 78, S117, 10.1259/bjr/15128198 Dworak, 1997, Pathological features of rectal cancer after preoperative radiochemotherapy, Int J Colorectal Dis, 12, 19, 10.1007/s003840050072 Kaplan, 1958, Non-parametric estimation from incomplete observations, J Am Statist Assoc, 53, 457, 10.1080/01621459.1958.10501452 Valentini, 2011, Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials, J Clin Oncol, 29, 3163, 10.1200/JCO.2010.33.1595 Pedersen, 2011, Postgraduate multidisciplinary development program: impact on the interpretation of pelvic MRI in patients with rectal cancer: a clinical audit in West Denmark, Dis Colon Rectum, 54, 328, 10.1007/DCR.0b013e3182031e83 Monig, 1999, Lymph node size and metastatic infiltration in colon cancer, Ann Surg Oncol, 6, 579, 10.1007/s10434-999-0579-1 Brown, 2003, Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison, Radiology, 227, 371, 10.1148/radiol.2272011747 Cassidy, 2008, Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer, J Clin Oncol, 26, 2006, 10.1200/JCO.2007.14.9898 Diaz-Rubio, 2007, J Clin Oncol, 25, 4224, 10.1200/JCO.2006.09.8467 Porschen, 2007, Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group, J Clin Oncol, 25, 4217, 10.1200/JCO.2006.09.2684 Maas, 2010, Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data, Lancet Oncol, 11, 835, 10.1016/S1470-2045(10)70172-8 Kim, 2005, Impact of pretreatment size and lymph nodes on pathological complete response and survival in a prospective trial of chemoradiation, Int J Radiat Oncol Biol Phys, 63, S164, 10.1016/j.ijrobp.2005.07.284 Peschaud, 2008, The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer, Ann Surg, 248, 1067, 10.1097/SLA.0b013e31818842ec Kim, 2009, The prognostic impact of the number of lymph nodes retrieved after neoadjuvant chemoradiotherapy with mesorectal excision for rectal cancer, J Surg Oncol, 100, 1, 10.1002/jso.21299 Klos, 2010, The effect of neoadjuvant chemoradiation therapy on the prognostic value of lymph nodes after rectal cancer surgery, Am J Surg, 200, 440, 10.1016/j.amjsurg.2010.03.013